✦ LIBER ✦

Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients

✍ Scribed by Kim, Inho; Koh, Youngil; Yoon, Sung-Soo; Park, Seonyang; Kim, Byoung Kook; Kim, Dae-Young; Lee, Jung-Hee; Lee, Kyoo-Hyung; Cheong, June-Won; Lee, Hong-Kee; Kim, Sung-Hyun; Kim, Hyuk; Joo, Young Don; Lee, Sang-Min; Won, Jong-Ho; Park, Sung-Kyu; Hong, Dae-Sik; Kim, Se-Hyung; Sohn, Sang Kyun; Kim, Chul-Soo; Park, Eunkyung; Kim, Min Kyoung; Park, Moo Rim; Lee, Je-Hwan; Min, Yoo Hong

Book ID: 118751068
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 240 KB
Volume: 88
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23337

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine, idarubicin, and cytarabine

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia

✍ Nazha, Aziz; Kantarjian, Hagop; Ravandi, Farhad; Huang, Xuelin; Choi, Sangbum; G 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

Salvage therapy for acute myeloid leukem

Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF

✍ Mike G. Martin; Kristan M. Augustin; Geoffrey L. Uy; John S. Welch; Lindsay Hlad 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

Reduced-intensity conditioning therapy w

Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome

✍ Gao, Li; Gao, Lei; Gong, Yi; Zhang, Cheng; Chen, Xing-Hua; Zhang, Xi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 662 KB

Low-dose cytarabine, aclarubicin and gra

Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia

✍ Jin, Jie; Chen, Jian; Suo, Shanshan; Qian, Wenbin; Meng, Haitao; Mai, Wenyuan; T 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 632 KB

Results of conventional-dose cytosine ar

Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia

✍ A. Heyll; C. Aul; F. Gogolin; V. Runde; D. Söhngen; G. Meckenstock; H. -H. Wolf; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 549 KB

Continuous infusion of intermediate-dose

Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study

✍ Hawk Kim; Jae-Hoo Park; Je-Hwan Lee; Jung-Hee Lee; Young-Don Joo; Won-Sik Lee; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views